TABLE II.

Benralizumab allowed some subjects to reduce medical therapies for EGID and liberalize dietary restrictions

No.	BL Tx	Diet at BL	Week 48 Tx	Diet at week 48
6*	P 10 mg daily, HU 1 g daily	Unrestricted	P 15 mg	Unrestricted
7	Budesonide 9 mg FV 440 twice a day	Avoids: chicken and beef plus FA foods	Budesonide 6 mg, FV 440 twice a day	No attempt to reintroduce foods; eats more freely
11	Budesonide 3 mg	Unrestricted	None	Unrestricted
13	None	Avoids: carrots, peas, apple, mango, banana, watermelon, kiwi, strawberry, turkey, direct egg, corn, wheat, oats	None	Reintroduced most foods Avoids: wheat and mango
14	FV 220 2p twice a day	Consumes only shrimp, potato, fruit (apple, pear, lemon, banana), vegetables (broccoli, lettuce)	FV 220 2p twice a day	Reintroduced fish, poultry, tomato, carrots. Unable to tolerate avocado and shrimp
15*	None	Unrestricted, but planned mealtimes to avoid symptoms	None	Eats unrestricted diet freely
16	FV 220 2p twice a day	Avoids: corn, rice, most meats, shrimp, shellfish, and pure egg	FV 220 2p twice a day	No attempts to reintroduce foods

Budesonide, Budesonide slurry; P, prednisone; FA, food allergy; FV, swallowed fluticasone; HU, hydroxyurea; Tx, treatment.

^*Subjects with lymphoid HES and GI involvement. Remaining subjects were HES single-organ overlap (EGID). Subject #6 relapsed at week 32 and taken off benralizumab.